{
  "id": "https://w3id.org/mircat/miflowcyt/schema/biological_sample_schema.json",
  "$schema": "http://json-schema.org/draft-04/schema",
  "title": "MIFlowCyt Biological Sample",
  "description": "Biological Sample",
  "type": "object",
  "properties": {
    "@context": {
      "description": "The JSON-LD context",
      "anyOf": [
        {
          "type": "string"
        },
        {
          "type": "object"
        },
        {
          "type": "array"
        }
      ]
    },
    "@id": {
      "description": "The JSON-LD identifier",
      "type": "string",
      "format": "uri"
    },
    "@type": {
      "description": "The JSON-LD type",
      "type": "string",
      "format": "uri"
    },
    "sampleDescription": {
      "description": "A description of the biological sample shall be provided, including the sample type, if relevant (e.g., C57BL/6 spleen, purified CD4+ lymphocytes, BALB/c thymocyte DNA, control patient PBMCs, protein lysate from lung cancer biopsy, peripheral blood from patient with Type I diabetes, liver biopsy, etc.)",
      "type": "string"
    },
    "sourceDescription": {
      "description": "The source of the biological sample shall be described (e.g., wild- type mouse, C57BL/6 spleen, C57BL/6 splenocytes). If the source is a cell line the description shall include its name, ATCC [17] (or equivalent) number, and cell type.",
      "type": "string"
    },
    "organism": {
      "description": "The source organism for this biological sample",
      "$ref": "organism_schema.json#"
    },
    "other": {
      "description": "Additional information about the biological sample should be provided if relevant. This may include relevant information such as in vivo or in vitro treatment, stimulation, preparation / enrichment protocol, culture/growth protocol, collection time/date, whether the sample was frozen/banked/fixed, etc.",
      "type": "string"
    }
  }
}